X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10331) 10331
Magazine Article (44) 44
Newsletter (41) 41
Book Chapter (6) 6
Newspaper Article (3) 3
Dissertation (2) 2
Publication (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8694) 8694
rifampin - therapeutic use (6964) 6964
male (4809) 4809
female (4332) 4332
adult (3616) 3616
rifampin (2945) 2945
middle aged (2842) 2842
isoniazid - therapeutic use (2371) 2371
antitubercular agents - therapeutic use (2354) 2354
drug therapy, combination (2318) 2318
tuberculosis (2020) 2020
tuberculosis, pulmonary - drug therapy (1933) 1933
infectious diseases (1879) 1879
rifampin - administration & dosage (1719) 1719
aged (1638) 1638
pharmacology & pharmacy (1568) 1568
adolescent (1520) 1520
microbiology (1468) 1468
animals (1466) 1466
rifampin - pharmacology (1427) 1427
anti-bacterial agents - therapeutic use (1422) 1422
ethambutol - therapeutic use (1369) 1369
tuberculosis - drug therapy (1207) 1207
treatment outcome (1205) 1205
microbial sensitivity tests (1034) 1034
child (1018) 1018
mycobacterium tuberculosis - drug effects (1005) 1005
rifampin - adverse effects (996) 996
pyrazinamide - therapeutic use (946) 946
time factors (845) 845
drug resistance (839) 839
antibiotics, antitubercular - therapeutic use (820) 820
rifampicin (766) 766
streptomycin - therapeutic use (741) 741
mice (698) 698
antibiotics (670) 670
child, preschool (668) 668
infections (664) 664
drug therapy (644) 644
drug resistance, microbial (635) 635
respiratory system (635) 635
mycobacterium tuberculosis - isolation & purification (616) 616
immunology (601) 601
pharmacokinetics (592) 592
young adult (587) 587
infant (579) 579
drug interactions (578) 578
isoniazid (564) 564
health aspects (561) 561
tuberculosis, multidrug-resistant - drug therapy (557) 557
diagnosis (551) 551
medicine, general & internal (551) 551
mycobacterium-tuberculosis (544) 544
retrospective studies (541) 541
isoniazid - administration & dosage (538) 538
research article (531) 531
infection (518) 518
leprosy - drug therapy (510) 510
analysis (499) 499
staphylococcal infections - drug therapy (499) 499
anti-bacterial agents - pharmacology (497) 497
research (497) 497
antitubercular agents - administration & dosage (496) 496
risk factors (492) 492
care and treatment (482) 482
antitubercular agents - pharmacology (479) 479
pulmonary tuberculosis (477) 477
therapy (468) 468
mycobacterium tuberculosis (465) 465
dapsone - therapeutic use (450) 450
follow-up studies (444) 444
sputum - microbiology (431) 431
drug administration schedule (416) 416
pyrazinamide (415) 415
tuberculosis, pulmonary - microbiology (410) 410
recurrence (403) 403
aged, 80 and over (398) 398
drugs (396) 396
drug resistance in microorganisms (388) 388
medicine (388) 388
mycobacterium tuberculosis - genetics (377) 377
antitubercular agents - adverse effects (372) 372
drug resistance, bacterial (368) 368
prospective studies (364) 364
patients (360) 360
mutation (358) 358
rifampin - pharmacokinetics (356) 356
bacteria (345) 345
leprostatic agents - therapeutic use (344) 344
anti-bacterial agents - administration & dosage (339) 339
dosage and administration (336) 336
chemotherapy (335) 335
drug combinations (334) 334
epidemiology (334) 334
hiv (328) 328
ethambutol (320) 320
administration, oral (312) 312
doxycycline - therapeutic use (312) 312
brucellosis - drug therapy (311) 311
isoniazid - pharmacology (305) 305
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8818) 8818
French (519) 519
German (249) 249
Russian (229) 229
Spanish (196) 196
Italian (195) 195
Japanese (185) 185
Portuguese (56) 56
Polish (55) 55
Chinese (51) 51
Romanian (45) 45
Dutch (24) 24
Turkish (23) 23
Hebrew (13) 13
Croatian (12) 12
Danish (10) 10
Norwegian (10) 10
Swedish (10) 10
Czech (4) 4
Korean (4) 4
Finnish (3) 3
Hungarian (3) 3
Lithuanian (3) 3
Slovak (3) 3
Serbian (2) 2
Bulgarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Current medical research and opinion, ISSN 1473-4877, 2012, Volume 29, Issue 1, pp. 1 - 12
Abstract Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system. Among numerous well... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | PHARMACOKINETICS | METABOLISM | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 39 - 49
Journal Article
The international journal of tuberculosis and lung disease, ISSN 1027-3719, 02/2008, Volume 12, Issue 2, pp. 128 - 138
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 2013, Volume 207, Issue 1, pp. 9 - 17
Background. Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this... 
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | tuberculosis | genotyping | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CARE | transmission | NEW-YORK-CITY | INFECTED PATIENTS | drug resistance | XDR-TB | OUTBREAK | SPREAD | STRAIN | EPIDEMIOLOGY | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Major and Brief Reports
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9979, pp. 1738 - 1747
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 1019 - 1024
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 3/2009, Volume 92, Issue 1, pp. 33 - 35
.... Its use poses higher risks of lymphopenia and opportunistic infections. Prophylaxis for Pneumocystis... 
Oncology | Opportunistic infections | Temozolomide | Medicine & Public Health | Lymphopenia | ONCOLOGY | RISK | RADIOTHERAPY | ANEMIA | PURE | RED-CELL APLASIA | CLINICAL NEUROLOGY | Dacarbazine - adverse effects | Red-Cell Aplasia, Pure - drug therapy | Heptanoic Acids - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Pulmonary - chemically induced | Dacarbazine - analogs & derivatives | Anti-Inflammatory Agents - therapeutic use | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Fluoxetine - therapeutic use | Pyrroles - therapeutic use | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Anti-Infective Agents - therapeutic use | Anticonvulsants - therapeutic use | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Brain Neoplasms - drug therapy | Radiotherapy | Pyrazinamide - therapeutic use | Atorvastatin Calcium | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Phenobarbital - therapeutic use | Anticholesteremic Agents - therapeutic use | Antibiotics, Antitubercular - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Prednisone - therapeutic use | Online health care information services | Pneumonia | Tuberculosis | Gliomas | Analysis | Bacterial pneumonia | Brain tumors | Pyrazinamide | Health aspects | Rifampin | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2016, Volume 2016, Issue 7, p. CD000299
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 17, pp. 1588 - 1598
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 17, pp. 1577 - 1587
Journal Article